These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 23331004)
21. Translating basic research in cancer patient care. Maugeri-Saccà M; De Maria R Ann Ist Super Sanita; 2011; 47(1):64-71. PubMed ID: 21430342 [TBL] [Abstract][Full Text] [Related]
22. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Cho WC Int J Biochem Cell Biol; 2010 Aug; 42(8):1273-81. PubMed ID: 20026422 [TBL] [Abstract][Full Text] [Related]
23. Biomarkers in cancer micrometastasis: where are we at? Gerges N; Jabado N Bioanalysis; 2010 May; 2(5):881-99. PubMed ID: 21083219 [TBL] [Abstract][Full Text] [Related]
24. Cancer biomarkers: an emerging means of detecting, diagnosing and treating cancer. Srivastava S Cancer Biomark; 2005; 1(1):1-2. PubMed ID: 17192027 [No Abstract] [Full Text] [Related]
25. Breast cancer stem cells: an update. Iqbal J; Chong PY; Tan PH J Clin Pathol; 2013 Jun; 66(6):485-90. PubMed ID: 23322821 [TBL] [Abstract][Full Text] [Related]
26. Development of molecular techniques for imaging and treatment of tumors. Haberkorn U; Markert A; Eisenhut M; Mier W; Altmann A Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):655-70. PubMed ID: 22231585 [TBL] [Abstract][Full Text] [Related]
27. Can lung cancer stem cells be targeted for therapies? Wu X; Chen H; Wang X Cancer Treat Rev; 2012 Oct; 38(6):580-8. PubMed ID: 22436486 [TBL] [Abstract][Full Text] [Related]
28. Cancer stem cells in oncology. Cetin I; Topcul M J BUON; 2012; 17(4):644-8. PubMed ID: 23335519 [TBL] [Abstract][Full Text] [Related]
29. A radical rethinking of treatment. The aim is to make cancer curable or a manageable chronic disease. Hobson K US News World Rep; 2008 Nov 3-10; 145(10):48-50, 53. PubMed ID: 18998442 [No Abstract] [Full Text] [Related]
34. Discrepancies between primary tumor and metastasis: a literature review on clinically established biomarkers. Vignot S; Besse B; André F; Spano JP; Soria JC Crit Rev Oncol Hematol; 2012 Dec; 84(3):301-13. PubMed ID: 22710198 [TBL] [Abstract][Full Text] [Related]
35. Origin of cancers. Clinical perspectives and implications of a stem-cell theory of cancer. Tu SM Cancer Treat Res; 2010; 154():v-239. PubMed ID: 20645140 [No Abstract] [Full Text] [Related]
36. Biomarker profiling for cancer diagnosis, prognosis and therapeutic management. Mitra AP; Lin H; Cote RJ; Datar RH Natl Med J India; 2005; 18(6):304-12. PubMed ID: 16483031 [TBL] [Abstract][Full Text] [Related]
38. Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy. Singh AP; Chaturvedi P; Batra SK Cancer Res; 2007 Jan; 67(2):433-6. PubMed ID: 17234748 [TBL] [Abstract][Full Text] [Related]
39. Targeting cancer stem cells with monoclonal antibodies: a new perspective in cancer therapy and diagnosis. Okamoto OK; Perez JF Expert Rev Mol Diagn; 2008 Jul; 8(4):387-93. PubMed ID: 18598221 [TBL] [Abstract][Full Text] [Related]
40. Introduction by the Guest Editor: Oligometastatic Disease in Cancer. Kim HS Cancer J; 2020; 26(2):95. PubMed ID: 32205531 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]